PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.\', \'Janssen Vaccines and Prevention, Leiden, Netherlands.\', \'Harvard Medical School, Boston, MA 02115, USA.\', \'Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA.\', \'BIOQUAL, Rockville, MD 20852, USA.\', \'Amsterdam University Medical Center, Amsterdam, Netherlands.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1126/scitranslmed.abm4996
?:hasPublicationType
?:journal
  • Science translational medicine
is ?:pmid of
?:pmid
?:pmid
  • 35191769
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 9.7
?:rankingScore_hIndex
  • 147
is ?:relation_isRelatedTo_publication of
?:title
  • A homologous or variant booster vaccine after Ad26.COV2.S immunization enhances SARS-CoV-2-specific immune responses in rhesus macaques.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35191769>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35191769>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all